Abstract:International Journal of Stroke, Volume 19, Issue 5, Page 482-489, June 2024. Intracerebral hemorrhage (ICH) is a devastating disease, causing high rates of death, disability, and suffering across the world. For decades, its treatment has been shrouded by the lack of reliable evidence, and consequently, the presumption that an effective treatment is unlikely to be found. Neutral results arising from several major randomized controlled trials had established a negative spirit within and outside the stroke community. Frustration among researchers and a sense of nihilism in clinicians has created the general perception that patients presenting with ICH have a poor prognosis irrespective of them receiving any form of active management. All this changed in 2023 with the positive results on the primary outcome in randomized controlled trials showing treatment benefits for a hyperacute care bundle approach (INTERACT3), early minimal invasive hematoma evacuation (ENRICH), and use of factor Xa-inhibitor anticoagulation reversal with andexanet alfa (ANNEXa-I). These advances have now been extended in 2024 by confirmation that intensive blood pressure lowering initiated within the first few hours of the onset of symptoms can substantially improve outcome in ICH (INTERACT4) and that decompressive hemicraniectomy is a viable treatment strategy in patients with large deep ICH (SWITCH). This evidence will spearhead a change in the perception of ICH, to revolutionize the care of these patients to ultimately improve their outcomes. We review these and other recent developments in the hyperacute management of ICH. We summarize the results of randomized controlled trials and discuss related original research papers published in this issue of the International Journal of Stroke. These exciting advances demonstrate how we are now at the dawn of a new, exciting, and brighter era of ICH management.

Evolving Therapeutic Landscape of Intracerebral Hemorrhage: Emerging Cutting-Edge Advancements in Surgical Robots, Regenerative Medicine, and Neurorehabilitation Techniques

Remote Diffusion-Weighted Imaging Lesions in Intracerebral Hemorrhage: Characteristics, Mechanisms, Outcomes, and Therapeutic Implications

Surgical Robotics for Intracerebral Hemorrhage Treatment: State of the Art and Future Directions

Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage.

Advances of nanotechnology for intracerebral hemorrhage therapy

Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions

Neuroendoscopic Parafascicular Evacuation of Spontaneous Intracerebral Hemorrhage (NESICH Technique): A Multicenter Technical Experience with Preliminary Findings

Application of biomaterials in the treatment of intracerebral hemorrhage

Mesenchymal Stem Cells Transplantation in Intracerebral Hemorrhage: Application and Challenges

Advancements in Managing Intracerebral Hemorrhage: Transition from Nihilism to Optimism

Editorial: Review on Intracerebral Haemorrhage: Multidisciplinary Approaches to the Injury Mechanism Analysis and Therapeutic Strategies.

Surgical Management for Primary Intracerebral Hemorrhage

Modern Approaches to Evacuating Intracerebral Hemorrhage

Treatment for intracerebral hemorrhage: Dawn of a new era

Minimally Invasive Treatment Options for Managing Spontaneous Intracerebral Hemorrhage

The Role of ICP Monitoring in Minimally Invasive Surgery for the Management of Intracerebral Hemorrhage

Intracerebral haemorrhage — mechanisms, diagnosis and prospects for treatment and prevention

Rebleeding after Minimally Invasive Surgery for Intracerebral Hemorrhage: A Mini-Review

Novel Therapeutic Mechanisms and Strategies for Intracerebral Hemorrhage: Focusing on Exosomes

Emergent Management of Intracerebral Hemorrhage

Application of emerging technologies in ischemic stroke: from clinical study to basic research